BWS
AXSM icon

Buck Wealth Strategies’s Axsome Therapeutics AXSM Stock Holding History

Buck Wealth Strategies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490 Buy
+2
New +$434 ﹤0.01% 1005

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Buck Wealth Strategies's AXSM Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 2 shares worth $490. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings.

203 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Buck Wealth Strategies held 2 shares of Axsome Therapeutics worth $490 as of Q2 2026.
  • Axsome Therapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1005 holding.
  • 203 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.